- Source: Lamivudine/tenofovir
Lamivudine/tenofovir disoproxil, sold under the brand name Cimduo among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS in adults and children weighing more than 35 kilograms (77 lb). It contains lamivudine and tenofovir disoproxil. It is taken by mouth.
Lamivudine/tenofovir was approved for medical use in the United States in February 2018.
References
Further reading
"WHO Public Assessment Report: HA414 - Lamivudine/Tenofovir disoproxil fumarate - 300mg/300mg - Tablets - Mylan Laboratories Ltd - India". World Health Organization (WHO). Archived from the original on 26 March 2020.
Kata Kunci Pencarian:
- Pemerkosaan
- Hepatitis B
- Dolutegravir/lamivudine/tenofovir
- Lamivudine/tenofovir
- Doravirine/lamivudine/tenofovir
- Efavirenz/lamivudine/tenofovir
- Lamivudine
- Tenofovir alafenamide
- WHO Model List of Essential Medicines
- Emtricitabine/tenofovir
- Dolutegravir/lamivudine
- ATC code J05
